Facile Electrochemically Reduced Graphene Oxide‐Multi‐walled Carbon Nanotube Nanocomposite as Sensitive Probe for in‐vitro Determination of Nitrofurantoin in Biological Fluids

2020 ◽  
Vol 32 (11) ◽  
pp. 2452-2462
Author(s):  
Shekher Kummari ◽  
V. Sunil Kumar ◽  
K. Vengatajalabathy Gobi
RSC Advances ◽  
2021 ◽  
Vol 11 (51) ◽  
pp. 31950-31958
Author(s):  
Fengxia Chang ◽  
Hongyue Wang ◽  
Shuai He ◽  
Yu Gu ◽  
Wenjie Zhu ◽  
...  

A novel reduced graphene oxide–polydopamine–carboxylated multi-walled carbon nanotube nanocomposite (RGO–PDA–cMWCNT) was fabricated for the sensitive and simultaneous determination of hydroquinone (HQ) and catechol (CT).


2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Gen Liu ◽  
Wei Ma ◽  
Yan Luo ◽  
Deng-ming Sun ◽  
Shuang Shao

Poly(methylene blue) and electrochemically reduced graphene oxide composite film modified electrode (PMB-ERGO/GCE) was successfully fabricated by electropolymerization and was used for simultaneous determination of uric acid (UA) and xanthine (Xa). Based on the excellent electrocatalytic activity of PMB-ERGO/GCE, the electrochemical behaviors of UA and Xa were studied by cyclic voltammetry (CV) and square wave voltammetry (SWV). Two anodic sensitive peaks at 0.630 V (versus Ag/AgCl) for UA and 1.006 V (versus Ag/AgCl) for Xa were given by CV in pH 3.0 phosphate buffer. The calibration curves for UA and Xa were obtained in the range of 8.00 × 10−8~4.00 × 10−4 M and 1.00 × 10−7~4.00 × 10−4 M, respectively, by SWV. The detection limits for UA and Xa were3.00×10-8 M and5.00×10-8 M, respectively. Finally, the proposed method was applied to simultaneously determine UA and Xa in human urine with good selectivity and high sensitivity.


2021 ◽  
Vol 13 (1) ◽  
pp. 56-63
Author(s):  
Qiuqiu Wang ◽  
Juanhua Zhang ◽  
Yanbo Xu ◽  
Yingyi Wang ◽  
Liang Wu ◽  
...  

One-step electrochemically reduced graphene oxide with high surface area and improved electron transfer kinetics shows great performances in the determination of furfural in dairy milk.


2015 ◽  
Vol 7 (4) ◽  
pp. 1471-1477 ◽  
Author(s):  
Siyuan Wang ◽  
Wen Zhang ◽  
Xia Zhong ◽  
Yaqin Chai ◽  
Ruo Yuan

A nanohybrid (RGO–PAMAM–MWCNT–AuNPs) for simultaneous electrochemical determination of ascorbic acid (AA), dopamine (DA) and uric acid (UA) was reported in this paper.


2020 ◽  
Vol 187 (5) ◽  
Author(s):  
Jagriti Sethi ◽  
Michiel Van Bulck ◽  
Ahmed Suhail ◽  
Mina Safarzadeh ◽  
Ana Perez-Castillo ◽  
...  

AbstractA label-free biosensor is developed for the determination of plasma-based Aβ1–42 biomarker in Alzheimer’s disease (AD). The platform is based on highly conductive dual-layer of graphene and electrochemically reduced graphene oxide (rGO). The modification of dual-layer with 1-pyrenebutyric acid N-hydroxysuccinimide ester (Pyr-NHS) is achieved to facilitate immobilization of H31L21 antibody. The effect of these modifications were studied with morphological, spectral and electrochemical techniques. The response of the biosensor was evaluated using differential pulse voltammetry (DPV). The data was acquired at a working potential of ~ 180 mV and a scan rate of 50 mV s−1. A low limit of detection (LOD) of 2.398 pM is achieved over a wide linear range from 11 pM to 55 nM. The biosensor exhibits excellent specificity over Aβ1–40 and ApoE ε4 interfering species. Thus, it provides a viable tool for electrochemical determination of Aβ1–42. Spiked human and mice plasmas were used for the successful validation of the sensing platform in bio-fluidic samples. The results obtained from mice plasma analysis concurred with the immunohistochemistry (IHC) and magnetic resonance imaging (MRI) data obtained from brain analysis.


Sign in / Sign up

Export Citation Format

Share Document